Potentiating antibacterial activity by predictably enhancing endogenous microbial ROS production
Open Access
- 6 January 2013
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Biotechnology
- Vol. 31 (2), 160-165
- https://doi.org/10.1038/nbt.2458
Abstract
The first global metabolic models that incorporate reactive oxygen species in E. coli reveal targets for potentiating the action of antibacterials. The ever-increasing incidence of antibiotic-resistant infections combined with a weak pipeline of new antibiotics has created a global public health crisis1. Accordingly, novel strategies for enhancing our antibiotic arsenal are needed. As antibiotics kill bacteria in part by inducing reactive oxygen species (ROS)2,3,4, we reasoned that targeting microbial ROS production might potentiate antibiotic activity. Here we show that ROS production can be predictably enhanced in Escherichia coli, increasing the bacteria's susceptibility to oxidative attack. We developed an ensemble approach of genome-scale, metabolic models capable of predicting ROS production in E. coli. The metabolic network was systematically perturbed and its flux distribution analyzed to identify targets predicted to increase ROS production. Targets that were predicted in silico were experimentally validated and further shown to confer increased susceptibility to oxidants. Validated targets also increased susceptibility to killing by antibiotics. This work establishes a systems-based method to tune ROS production in bacteria and demonstrates that increased microbial ROS production can potentiate killing by oxidants and antibiotics.Keywords
This publication has 35 references indexed in Scilit:
- Antibiotic-Resistant Bugs in the 21st Century — A Clinical Super-ChallengeThe New England Journal of Medicine, 2009
- Mistranslation of Membrane Proteins and Two-Component System Activation Trigger Antibiotic-Mediated Cell DeathCell, 2008
- Bleach Activates a Redox-Regulated Chaperone by Oxidative Protein UnfoldingCell, 2008
- Accelerated evolution of resistance in multidrug environmentsProceedings of the National Academy of Sciences of the United States of America, 2008
- The growing scope of applications of genome-scale metabolic reconstructions using Escherichia coliNature Biotechnology, 2008
- A genome‐scale metabolic reconstruction for Escherichia coli K‐12 MG1655 that accounts for 1260 ORFs and thermodynamic informationMolecular Systems Biology, 2007
- Gyrase inhibitors induce an oxidative damage cellular death pathway in Escherichia coliMolecular Systems Biology, 2007
- Networks from drug–drug surfacesMolecular Systems Biology, 2007
- Construction of Escherichia coli K‐12 in‐frame, single‐gene knockout mutants: the Keio collectionMolecular Systems Biology, 2006
- Integrating high-throughput and computational data elucidates bacterial networksNature, 2004